BUSINESS5 years ago
Zogenix, Inc. (NASDAQ:ZGNX) Fails To Produce Impressive Reductions In Seizures With Its Clinical Trial Drug Fintepla
Zogenix, Inc. (NASDAQ:ZGNX) has reported positive results for its drug – Fintepla during the clinical trial to treat Lennox-Gastaut syndrome. However, the drug failed to produce...